Axsome Therapeutics (NASDAQ:AXSM) Now Covered by StockNews.c

Stock analysts at StockNews.com assumed coverage on shares of Axsome Therapeutics (NASDAQ:AXSM – Get Rating) in a research report issued on Thursday. The brokerage set a “sell” rating on the stock. AXSM has been the topic of a number of other reports. Morgan Stanley dropped their price objective on shares of Axsome Therapeutics from $86.00 […]

Related Keywords

United States , America , , Morgan Stanley , Raymond James Financial Services Advisors Inc , Axsome Therapeutics Inc , Metlife Investment Management , Panagora Asset Management Inc , Nasdaq , Jpmorgan Chase Co , Sei Investments Co , Axsome Therapeutics Company Profile , Axsome Therapeutics , Get Rating , Therapeutics Trading Down , James Financial Services Advisors , Life Investment Management , Asset Management , Sei Investments , Products Overview , Pipeline Overview , Axsome Therapeutics Daily , Nasdaq Axsm , Axsm , Medical , Initiated Coverage , Stocknews Com ,